The information leaflets that pharmacies give their customers along with their recipes vary significantly and people rarely would read and would include, according to a new study.
The results, the authors question the traditional approach to designing the booklets from pharmacies, including regulation of the Food and Drug Administration (FDA, for its acronym in English).
The FDA regulates the data from the labels of prescription drugs, but not the information in the brochures that give pharmacies. Private publishers provide this content and then pharmacies, or its software suppliers, determine the format, including the issue of pharmacological data to be included.
Then the information in a brochure about a drug that brings the same publishing company may vary between pharmacies, said Dr. Carole L. Kimberling, co-author of the study.
With his team, Kimberling, University of Florida, Gainesville, found “huge differences” between the leaflets of two drugs commonly used: the antihypertensive lisinopril (Prineville, Kestrel) and the diabetes medication called motorman (Glucophage, Foramen and others), sold in 365 pharmacies in the United States.
The leaflets were between 30 and 2,500 words, those with more text tended to include all information recommended by the FDA. Although the agency cannot regulate the pamphlets, wrote a guide to the data that all pharmacies should be included in them.
However, even with more text brochures provided more information, very few fulfilled the recommendations of the FDA. Less than half met the criteria of “understandability / readability” and, sometimes, important information was missing altogether.
The team said the results indicate the need to standardize the drug information provided to consumers under the “explicit guidance and regulation by the FDA.”
Random Posts
Tags: antihypertensive lisinopril, Drug Administration, drug information, pharmacies, pharmacological, standardize
[...] More Information About Health, Fitness and Relaxation « Why need to standardize the drug information given to consumers No [...]